Astellas Pharma US, Inc. has issued a recall for one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg ...

The FDA receives reports from food companies almost daily regarding potential allergens or foodborne illnesses. Here's a look ...

"This is to inform you that Biocon Pharma Limited, a wholly owned subsidiary of the company, has received approval for ...

In recent developments that concern public health and safety, two major pharmaceutical companies have issued urgent recalls ...

Bangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...

Background: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including ...

The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for “presence of foreign tablets/capsules” in the affected lot. One 0.5 mg Tacrolimus ...

The approval further adds to Biocon's portfolio of complex drug products and will be commercialised in the region ...

Topical tacrolimus is effective against lichen sclerosus in female adults, and Ebert et al. have now shown that tacrolimus ointment is a safe adjuvant treatment for lichen sclerosus in boys after ...

Aim: Little information is available regarding the influence of CYP3A5 genetic polymorphisms on tacrolimus dose requirement in pediatric liver transplantation. Patients & methods: We performed a ...

United States, Phoenix, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Glenmark Pharmaceuticals announced that it received final approval from the United States Food and Drug Administration (U.S. FDA) for its 0.03 ...